Objectives: Examining the spatial patterns of diffuse large B-cell lymphoma (DLBCL) incidence and residential proximity to toxic release locations may provide insight regarding environmental and sociodemographic risk factors.
D
iffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma (NHL) in the Western world, comprising approximately one-third of adult lymphomas. We previously examined spatial patterns of NHL incidence, the association between NHL incidence and distance to benzene release sites, 1 and racial differences in incidence and outcomes for DLBCL and other NHL subtypes. [1] [2] [3] Biologically, exposure to industrial volatile organic compounds such as benzene produces chromosomal aberrations and genetic changes. Some effects can occur at air levels of ≤1 ppm, suggesting that even low levels of chronic exposure can be harmful. 4 Our group was intrigued by reports that DLBCL risk is associated with residential proximity to industrial facilities, 5 data indicating that race and socioeconomic status are strongly associated with residential proximity to Toxics Release Inventory (TRI) facilities, [6] [7] [8] [9] and our findings of racial differences in DLBCL incidence, presentation, and outcome. 2, 10, 11 As such, we sought to examine socioeconomic and racial differences in the spatial epidemiology of DLBCL and assess the relation between DLBCL incidence and residential distance from TRI exposure sites.
Methods
We linked geocoded data on toxic release sites in Georgia between 1988 and 1998 from the Environmental Protection Agency's (EPA's) TRI, DLBCL incidence from the Georgia Comprehensive Cancer Registry (GCCR) from 1999 to 2008, and census tract population and demographic data from the 2000 US Census. This study was approved by the Emory University and the Georgia Department of Public Health institutional review boards.
Toxic Release Site Data
The EPA requires that facilities meeting thresholds defined by Section 313 of the Emergency Planning and Community Right-to-Know Act (42 USC 11001-11050) report annually their disposal or releases for listed toxic chemicals. 12 Launched in 1987, the TRI captures release information about certain chemicals, including quantities, media type, and geographic coordinates of releases from sources such as manufacturing facilities, service businesses, and federal facilities. 12 We measured and geocoded data for TRI sites in Georgia.
Census Tract Population and Demographic Data
During the 2000 US Census, there were 1618 census tracts within the state of Georgia. Population and demographic data were available from US Census Summary File 1 for 1616 of these tracts. 13 We used the percentage of individuals in each census tract living below the federal poverty level as a metric for socioeconomic status (SES) and determined the racial composition of each tract. We used census data on median year moved into residence (MYMI) derived from a sample of individuals residing within a census tract to estimate the length of time that residents were living in their current home as a surrogate for duration of residential exposure to TRI sites.
GCCR Data
GCCR provided data for all incident DLBCL cases among adults (20 years old and older) residing in Georgia at diagnosis during the period 1999-2008 using International Classification of Diseases for Oncology, First Revision codes from the World Health Organization-based classification of lymphoid neoplasms for epidemiologic research from InterLymph. 14 We previously examined national population-level incidence data for DLBCL and other NHL subtypes.
2,3,10,11,15 SEER*Stat (Surveillance, Epidemiology, and End Results program) version 7.05 (National Cancer Institute, Bethesda, MD) was used to access the SEER 13 Registries Database and standardize the DLBCL incidence rates from Georgia to national DLBCL incidence rates. 16 Age-, sex-, and race-specific crude DLBCL incidence rates were obtained for the 1999-2008 period to standardize Georgia census tract incidence data by age, sex, and race.
Subjects in the GCCR without age, sex, or race information were excluded from all of the analyses. We used four major race categories (white, African American, American Indian/Alaskan Native, and Asian or Pacific Islander); we excluded subjects whose race was categorized as "other" or "unknown." Successfully geocoded cases were aggregated to the census tract level.
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Standardized incidence ratios (SIRs) were calculated for each census tract by dividing the number of observed cases by expected cases.
Geographic Data and Spatial Analyses
We used the geographic information system (GIS) ArcGIS 10 (ESRI, Redlands, CA) to examine the spatial distribution of TRI sites and SIRs by census tract. Census tract shapefiles were obtained from the US Census Bureau's 2000 TIGER/Line files. 13 GIS software calculated distances from the 1618 census tract centroids to each toxic release site. Choropleth maps depict the DLBCL SIRs by census tract. Locations of TRI sites were overlaid on the SIR maps. Choropleth maps also were created to depict DLBCL incidence, percentage of individuals living below the federal poverty level, and racial composition by census tract in relation to TRI sites. Because sparse data can pose statistical problems in small area analyses, spatial smoothing also was performed to allow census tracts to borrow information from spatial neighbors and produce more stable estimates of SIRs while maintaining geographic precision. Specifically, spatial Empirical Bayes smoothing was performed on the SIR values using GeoDa 1.01 (Luc Anselin, Tempe, AZ). 18 We defined "neighbors" as census tracts with common borders or vertices and constructed choropleth maps of SIRs for DLBCL.
To assess the spatial correlation of SIRs, we conducted global and local spatial analyses. A global measure of spatial autocorrelation, Moran's I, was calculated for SIR patterns of DLCBL using GeoDa. To measure spatial autocorrelation at the local scale, local Moran's I, also called local indicators of spatial autocorrelation (LISA), 18 was calculated for SIR patterns of DLBCL using GeoDa. LISA cluster maps were created to identify the locations of any significant clusters of SIRs. Both the global and local spatial statistics based significance on 999 Monte Carlo simulations, with neighbors defined as above. 18 We tested for focal clustering, using the observed cases and the population at risk in each census tract to test the null hypothesis that there was no spatial clustering near the TRI sites (the foci). The Lawson-Waller score test was used to assess individually each of the sites for focal clustering of DLBCL. 18 Each census tract was scored for the difference between the observed and expected counts of DLBCL, weighted by inverse distance from each census tract centroid to the focus. 18 The LawsonWaller test statistic for site i is the following:
where c j is the number of observed cases in census tract j, n j is the population of census tract j, W ij is the inverse distance between census tract j and site i, C is the total number of cases, and n is the total population at risk. The standard normal distribution was used to estimate upper-tail P values. Because this test was conducted once for each release site, we adjusted our significance level using the Bonferroni correction. 19 Poisson regression models were constructed under the assumption that the number of observed incident cases for each census tract had a Poisson distribution where the expected number of cases for that census tract was based on local age, sex, and race demographics, and the explanatory variable was mean distance from the TRI sites. The census tract measures of SES and MYMI were assessed as potential confounders and/or effect modifiers. The models were estimated with the maximum likelihood method using SAS version 9.3 (SAS Institute, Cary, NC).
Results
From 1988 to 1998, Georgia facilities reported the release of 1,3 butadiene (3 sites), 2,4-D (1 site), benzene (19 sites), ethylene oxide (7 sites), formaldehyde (60 sites), pentachlorophenol (5 sites), styrene (86 sites), tetrachloroethylene (33 sites), and trichloroethylene (TCE, 40 sites). Total releases per site, calculated as the sum of fugitive air releases, stack air releases, and surface water discharges were 250 lb of 2,4-D and ranged from 52 to 3,830,097 lb of benzene; 171,437 to 216,659 lb of 1,3 butadiene; 4220 to 581,077 lb of ethylene oxide; 5 to 872,835 lb of formaldehyde; 164 to 3845 lb of pentachlorophenol; 2 to 4,472,334 lb of styrene; 5 to 1,575,644 lb of tetrachloroethylene; and 5 to 3,730,069 lb of TCE. Of the 4316 incident cases of DLBCL in our original dataset, 3857 cases were successfully geocoded to census tracts. Among these, 3581 (92.8%) cases had age, sex, and race information available to be classified into the US Census race categories ( T1 Table 1 ). We mapped SIRs for DLBCL with location data for each TRI site ( F1 Fig. 1 ). Two census tracts were not included because of a lack of demographic data.
Spatial Analyses
We found no evidence of global spatial correlation of SIRs among all of the cases or cases restricted to specific age, sex or race subgroups at the α = 0.0071 level (Bonferroni adjusted for seven comparisons); however, LISA cluster maps of SIRs ( F2 Fig. 2 Fig. 2) . High-high clustering of DLBCL was primarily located in the northern half of the state and low-low clustering in the southern half. Among all of the cases, mean distance to formaldehyde release sites had the strongest effect, with a 0.58% decrease in DLBCL risk expected for every mile that the distance to formaldehyde release sites increased (P < 0.0001). Tables 2 to 5 show the results of the Poisson regression analyses. The relative risk is equal to exp(β 1 ); in other words, increasing mean distance to TRI sites by 1 mi decreases the risk of DLBCL by 1 − exp (β 1 ). Mean distance from 1,3-butadiene, 2,4-D, benzene, ethylene oxide, formaldehyde, styrene, tetrachloroethylene, and TCE release sites associated significantly with DLBCL incidence, whereas mean distance from pentachlorophenol sites did not. No statistically significant Poisson coefficients emerged for the interaction term between mean distance to TRI sites and the percentage of individuals living below the poverty level or MYMI; as such, these variables were removed from multivariable models. In addition, comparing models that included these variables with those that did not suggested that these were not confounders in the relation between mean distance to TRI sites and DLBCL incidence. Notably, the effect of mean distance from all of the release sites on DLBCL incidence was strongest for African Americans (Table 3) . Relations among percentage of individuals living below the poverty level, racial composition of census tracts, DLBCL incidence, and proximity to TRI sites are displayed using choropleth maps in Table 6 ). Significant focal clustering was observed around TRI sites, and the rates of clustering around sites differed by race.
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Discussion
Numerous studies support associations between occupational toxic exposures and NHL incidence, [20] [21] [22] although considerable controversy remains regarding residential exposures. 5, 23, 24 Our study examined relations between incidence of DLBCL at the census tract level and toxic release sites to determine whether DLBCL incidence varies with distance from these sites. We identified areas of spatial clustering of DLBCL, which appeared to be high in the metropolitan Atlanta region and low in the southern areas of the state. All nine toxic release exposures showed some evidence for focal clustering, but not every site harbored a cluster of increased DLBCL incidence. The potential reasons for significantly increased DLBCL incidence around certain sites but not others include spurious associations, differences in levels of exposure, and differences in other covariates influencing risk. We have attempted to address the latter by adjusting for age, sex, and race in risk estimates and examining SES and MYMI as potential confounders, but other known and unknown unadjusted factors may influence DLBCL risk. Notably, release sites with significant focal clustering tended to occur in areas with higher population density, primarily in the metropolitan Atlanta region, even though our analyses adjusted for this factor. We based our study on the underlying assumption that increased exposure to the chemicals emerging from TRI facilities can produce an elevated risk of lymphoma and used mean distance between residence and emission facilities as an indicator of exposure. All of the chemicals investigated are volatile organic compounds for which indoor sources and outdoor sources may contribute to personal exposure. Outdoor sources include point sources (eg, TRI facilities), nonpoint, on-road, secondary, and background sources. In addition, chemical exposures from TRI facilities depend not only on distance but also on wind speed, direction, water, and other sources. Accordingly, these data should not be used alone to determine environmental policy regarding DLBCL. Instead, our results aid in identifying candidate organic compounds that can be measured directly in epidemiological studies of individuals at risk and can aid in identifying populations in which such measurement should be performed.
One key strength of our study is the use of publicly available data from the EPA and the US Census Bureau. The racial and SES composition of the state of Georgia, which varied by region, provided a distinct opportunity to investigate relations among race, TRI exposure, and DLBCL incidence. Our study, however, was limited by the use of aggregated data, and the associations observed at the census tract level may not hold true at the individual level. Furthermore, the presence of chemical releases into the environment is not sufficient to determine personal exposure or to calculate potential risks to human health. Additional studies are needed that directly measure individuals' blood toxin levels and examine their association with DLBCL incidence. Such studies could be targeted toward populations designated to be at increased risk by residential proximity and could provide corroborating evidence for the relation between these exposures and DLBCL. For approximately 18% of patients with DLBCL, accurate location data were missing, thereby precluding their inclusion in the geospatial analyses. We compared the DLBCL cohort included in the geospatial analysis with patients with DLBCL from the original full dataset of the GCCR and found no significant differences in race (P = 0.87) or sex (P = 0.43) using χ 2 tests, or age (P = 0.13) using a t test comparing those who were geocoded with a census tract and those who were not geocoded.
Another potential weakness of our study was the lack of quantitative exposures and temporal analyses. We attempted to control for time and latency by including only toxic release sites from 1988 to 1998 and using incidence and population data from 1999 to 2008, as well as assessing MYMI as a potential confounder and effect modifier. In addition, our estimate of exposure, mean distance to TRI sites for each census tract, does not include the quantity of chemicals released, which could improve estimates of cumulative exposure. In addition, mean distance may yield a lower exposure for tracts close to one site but far from other sites, which may result in an unreasonably low estimate for exposure. Future directions should include development of methods for estimating cumulative exposure as a function of distance to site, quantity of release at each site, and weather factors such as average wind patterns and speeds. Other possible sources of bias include changes in the population of Georgia from 1999 to 2008 and the use of 2000 US Census data as denominators for incidence rates. Because of these and other limitations, this work cannot be used to specifically delineate exposures that cause DLBCL.
Although causative etiologies remain unknown for most lymphomas, factors that influence the risk of developing lymphoma include genetics; environmental factors such as exposures to ultraviolet radiation, pesticides, or hair dyes; and comorbid diseases or their treatments, especially those that cause significant immunosuppression. 25 Advances in genomics support a genetic basis for etiologic commonality among lymphomas and for heterogeneity underlying distinct subtypes [26] [27] [28] [29] [30] and suggest that immune dysfunction is of greater etiologic importance for DLBCL than other lymphoma subtypes. 25 As a result, many studies of lymphomagenesis have focused on genes involved in inflammatory pathways and in lymphoid development. 31, 32 Research also has shown that the relation between a toxic exposure and NHL risk may be modified by particular variants in immunoregulatory genes, suggesting a need for further studies of gene-environment interactions. 31 Several case-control studies have explored environmental exposures potentially associated with DLBCL and NHL. Researchers obtained 20-year residential histories for 1321 NHL cases and 1057 controls in four US SEER centers and detected clusters of significantly elevated risk in one of the study areas (Los Angeles) at a lag time of 20 years (P = 0.03). 33 Another study examined the residential locations in four SEER regions during the 10 years before recruitment to characterize the impact that proximity to industrial facilities had on developing NHL. This study found that living within 2 mi of a lumber facility was associated with increased DLBCL risk, but it did not provide strong evidence that living near manufacturing industries increases NHL risk overall. 5 Although some studies have found associations between increased lymphoma risk and ultraviolet radiation, chemicals (particularly benzene and TCE), agricultural exposures, and hair dyes, debate remains regarding these relations generally and for DLBCL specifically. [34] [35] [36] [37] [38] [39] [40] Novel approaches are needed to integrate clinical and genomic data from lymphoma patients with residential exposure data to identify the effects of toxic exposures on molecular and cellular pathways. Early efforts in this arena are under way. 41 The results of our study also lend insight into the possible interplay among race, environmental factors, and DLBCL. It has been well established that there are significant racial differences in DLBCL incidence. Based on data from 37,009 cases of DLBCL in the SEER registry, whites in the United States have an ageadjusted incidence of 7.36/100,000 in the population and African Americans have an incidence of 4.88/100,000, with African American patients more commonly presenting with DLBCL at 60 years old and younger (65% vs 37%); this indicates that there are racial differences in the rates and patterns of DLBCL development. 2 In addition, racial and socioeconomic disparities have been described with regard to exposure to airborne toxins, with benzene being one of the largest contributors. 6 The magnitude of disparity is highest in the poorest and most highly concentrated areas in which African Americans reside.
Although the effect of mean distance from certain TRIs on DLBCL incidence was stronger for African Americans and the patterns of focal clustering of DLBCL cases around EPA TRI sites differed by race, these patterns did not appear to be related to differences in racial population distributions across Georgia. These data suggest racial differences in the magnitude of exposure, genetic susceptibility to toxic exposures, or other factors that can contribute to increased risk. This study is the first to our knowledge to assess the relation among multiple toxic release exposures, race, and the incidence of a specific NHL subtype and can provide a foundation for future work. 
